A recurrence-predictive model based on eight genes and tumor mutational burden/microsatellite instability status in Stage II/III colorectal cancer.
Zhaoya GaoZhiyi WanPengfei YuYan ShangGuangsheng ZhuHuiyuan JiangYawei ChenShengzhou WangFuming LeiWensheng HuangQingmin ZengYanzhao WangWanshui RongYuming HongQingkun GaoPengfei NiuZhichao ZhaiKe AnChangmin DingYunfan WangGuoli GuXin WangQingkai MengShengwei YeHaiyi LiuJin GuPublished in: Cancer medicine (2023)
In conclusion, the G8plus score is a powerful biomarker for predicting the risk of recurrence in patients with stage II/III CRC. It can be used to stratify patients who benefit from ACT and immunotherapy.
Keyphrases